Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedling with methotrexate versus intralesional steroid for localized vitiligo
PACTR202607567738879Phase 3Unknown
- Sponsor
- Al-Azhar University
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of methotrexate in Vitiligo (2 arms), sponsored by Al-Azhar University. Primary endpoint: Degree of repigmentation. Status: unknown.
02
Drugs
methotrexate
03
Conditions
Vitiligo
Beyond the preview
Go deeper on PACTR202607567738879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202607567738879.